EQS-News: PharmaSGP continues the profitable growth course of the previous quarters in the third quarter of 2023
Gräfelfing, November 14, 2023 – German OTC pharmaceutical company PharmaSGP Holding SE continued the positive business development of the previous quarters in the third quarter of 2023.
- Gräfelfing, November 14, 2023 – German OTC pharmaceutical company PharmaSGP Holding SE continued the positive business development of the previous quarters in the third quarter of 2023.
- Based on preliminary, unaudited figures, quarterly revenues of € 26.0 million once again exceeded the figures for the two previous quarters of the year.
- Overall, PharmaSGP generated revenues of € 75.7 million in the first nine months of 2023.
- With year-on-year growth of 21.3%, adjusted earnings before interest, taxes, depreciation and amortization (adjusted EBITDA) amounted to € 24.7 million in the 2023 reporting period.